The healthcare architecture in England is changing. To support integration of care services, the government's white paper, Integration and Innovation, sets out a plan to establish statutory integrated care systems (ICSs). These bodies will replace and take over commissioning functions from clinical commissioning groups (CCGs) in April 2022, moving to a strategic resource planning approach.
- Ahead of this transition, this report reflects on the crucial role and functions that CCGs' medicines optimisation teams currently deliver in the existing healthcare architecture to improve patient care.
- ICS are tasked with enabling system working, collaboration and integration.
- In supporting this report, NHS Clinical Commissioners hopes that ICSs and national policymakers will build their knowledge of CCG medicines optimisation and ensure the safe transfer of it as a commissioning function within the new architecture.
- This paper sets out four main themes which outline the role and functions of CCG medicines optimisation teams: medicines commissioning; medicines finance, medicines safety and quality; medicines across the system.
- We have included a diagram to show most of the roles and functions which sit under the headings, but the list continuously eveloves and this iteration should not be considered to be exhaustive.
- As ICSs start to take place in their shadow form, we hope that the role of medicines optimisation is truly considered in advance of structures and governance processes established.